ACA
REGN icon

Atlas Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.07M Sell
7,758
-700
-8% -$368K 0.5% 49
2025
Q1
$5.36M Sell
8,458
-8
-0.1% -$5.07K 0.67% 42
2024
Q4
$6.03M Buy
8,466
+8,318
+5,620% +$5.93M 0.77% 37
2024
Q3
$156K Sell
148
-8,334
-98% -$8.76M 0.02% 416
2024
Q2
$8.91M Buy
8,482
+8,331
+5,517% +$8.76M 1.16% 21
2024
Q1
$145K Sell
151
-8,334
-98% -$8.02M 0.02% 424
2023
Q4
$7.45M Hold
8,485
1.08% 22
2023
Q3
$6.98M Hold
8,485
1.15% 21
2023
Q2
$6.1M Sell
8,485
-2
-0% -$1.44K 0.92% 25
2023
Q1
$6.97M Hold
8,487
1.1% 23
2022
Q4
$6.12M Hold
8,487
1.03% 24
2022
Q3
$5.85M Sell
8,487
-15
-0.2% -$10.3K 1.06% 21
2022
Q2
$5.03M Buy
8,502
+20
+0.2% +$11.8K 0.85% 26
2022
Q1
$5.92M Buy
8,482
+9
+0.1% +$6.29K 0.92% 29
2021
Q4
$5.35M Hold
8,473
0.8% 31
2021
Q3
$5.13M Hold
8,473
0.82% 30
2021
Q2
$4.73M Hold
8,473
0.79% 29
2021
Q1
$4.01M Sell
8,473
-296
-3% -$140K 0.78% 29
2020
Q4
$4.24M Sell
8,769
-340
-4% -$164K 0.89% 27
2020
Q3
$5.1M Buy
9,109
+530
+6% +$297K 1.21% 16
2020
Q2
$5.35M Buy
8,579
+121
+1% +$75.5K 1.26% 12
2020
Q1
$4.13M Hold
8,458
1.23% 14
2019
Q4
$3.18M Hold
8,458
0.79% 24
2019
Q3
$2.35M Hold
8,458
0.71% 23
2019
Q2
$2.65M Hold
8,458
0.87% 16
2019
Q1
$3.47M Hold
8,458
1.25% 11
2018
Q4
$3.16M Hold
8,458
1.27% 10
2018
Q3
$3.41M Hold
8,458
1.14% 15
2018
Q2
$3.09M Hold
8,458
1.1% 14
2018
Q1
$2.91M Buy
+8,458
New +$2.91M 0.89% 15